Tracelink Improves Serialization with the Implementation of GS1 EPCIS 1.1
FREMONT, CA: To eliminate the counterfeit prescription drugs from the global marketplace, TraceLink, a life science based company effectively completed an industrial pilot for Drug Supply Chain Security Act (DSCSA) compliance of GS1 EPCIS 1.1 Data Exchange on the Life Science Cloud. TraceLink works with life sciences supply chain companies in caring patients and save their lives; and improves industrial business with innovative track and trace solutions.
“EPCIS has always been a core component of the Life Sciences Cloud to ensure the pharmaceutical supply chain will be able to exchange and manage the massive volume of data and transactions that will occur as global markets transition to item-level drug serialization, starting with the US in 2017,” says Shabbir Dahod, CEO and President, TraceLink.
The Life Sciences Cloud is a network platform aimed at delivering safe medicines to patients anywhere, providing a global connectivity to all the supply chain partners with a single click. Cloud integrated to the supply chain system of life science offers real-time visibility across the network chain, provides up-to-the-minute inventory stocks with other partners; the trace and track ability minimizes the risk, cost and time to meet global serialization and helps in enabling a two-way communication channel between the patients and pharmacists.
TraceLink conducted pilot on five pharmaceutical manufacturers and one wholesale distributor in US, adding many industries to the list. TraceLink’s successful accomplishment of tests placed the company to the apex in life sciences industry, supporting large-scale commercial EPCIS deployments marking about 69,000 properly serialized shipments globally. The implementation of GS1 EPCIS 1.1 following Brazil Medicine Traceability Guideline data exchange standards connected Roche, a user of TraceLink’s solution to the other supply chain partners. Shabbir said, “To be live in production supporting serialized product with EPCIS 1.1 messages for DSCSA more than a year before the November 2017 deadline.”
By John Kamin, EVP and CIO, Old National Bancorp
By Gregg T. Martin, VP & CIO, Arnot Health
By Dave Doyle, CIO & SVP, IT, Regal Entertainment Group
By Sergey Cherkasov, CIO, PhosAgro
By Adrian Mebane, VP-Global Ethics & Compliance, The Hershey...
By Mike Fitton, Wireless Business Unit Director, Altera
By Jim Kaskade, VP and GM, Big Data & Analytics, CSC
By Thomas Musgrave, EVP & CIO, AmeriCold Logistics
By Vin Sharma, Director, Strategic Planning & Marketing, Big...
By Federico Flórez, Chief Information & Innovation Officer,...
By Barbara Adams, VP, Innovative Technology Solutions, Texas...
By John Mason, CIO, Bottomline Technologies
By Jamshid Khazenie, CTO, USA Today Network / Gannett
By Miguel Gamino, CIO & Executive Director-Department of...
By Bill Schimikowski, VP, Customer Experience, Fidelity...
By Tom Bressie, Vice President, Oracle Cloud
By John Landwehr, Public Sector CTO, Adobe
By Aaron Gette, CIO, The Bay Club Company
By Denise Zabawski, CIO, Nationwide Children's Hospital
By Amit Bahree, Executive, Global Technology and Innovation,...